247 related articles for article (PubMed ID: 6685108)
21. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study.
Azoulay D; Castaing D; Dennison A; Martino W; Eyraud D; Bismuth H
Hepatology; 1994 Jan; 19(1):129-32. PubMed ID: 8276348
[TBL] [Abstract][Full Text] [Related]
22. [Corneal manifestations in Vitamin A deficiency].
Sadowski B; Rohrbach JM; Steuhl KP; Weidle EG; Castrillón-Oberndorfer WL
Klin Monbl Augenheilkd; 1994 Aug; 205(2):76-85. PubMed ID: 7967410
[TBL] [Abstract][Full Text] [Related]
23. Use of the retinol-binding protein: transthyretin ratio for assessment of vitamin A status during the acute-phase response.
Filteau SM; Willumsen JF; Sullivan K; Simmank K; Gamble M
Br J Nutr; 2000 May; 83(5):513-20. PubMed ID: 10953676
[TBL] [Abstract][Full Text] [Related]
24. Taste alterations in liver cirrhosis: are they related to zinc deficiency?
Sturniolo GC; D'Incà R; Parisi G; Giacomazzi F; Montino MC; D'Odorico A; Soranzo P; Naccarato R
J Trace Elem Electrolytes Health Dis; 1992 Mar; 6(1):15-9. PubMed ID: 1638179
[TBL] [Abstract][Full Text] [Related]
25. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt.
Spahr L; Fenyves D; N'Guyen VV; Roy L; Legault L; Dufresne MP; Pomier-Layrargues G
Am J Gastroenterol; 1995 Jul; 90(7):1169-71. PubMed ID: 7611221
[TBL] [Abstract][Full Text] [Related]
26. Transjugular intrahepatic portosystemic shunt prior to cardiac surgery with cardiopulmonary bypass in patients with cirrhosis and portal hypertension.
Semiz-Oysu A; Moustafa T; Cho KJ
Heart Lung Circ; 2007 Dec; 16(6):465-8. PubMed ID: 17446133
[TBL] [Abstract][Full Text] [Related]
27. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB
Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326
[TBL] [Abstract][Full Text] [Related]
28. [Biological criteria of denutrition. Search of significant parameters for diagnosis and management in surgical departments].
Cals MJ; Drevillon C; Raffray Y; Succari M; Delacoux E; Evstigneeff T; Desmoulins D; Arsac M; Miocque M
Sem Hop; 1982 Dec; 58(48):2833-7. PubMed ID: 6302850
[TBL] [Abstract][Full Text] [Related]
29. Intraparenchymal anesthesia infiltration during transjugular intrahepatic portosystemic shunting.
Pulido-Duque JM; Reyes R; Górriz E; Cabrera J; Rostagno R; Castaneda-Zuniga WR; Maynar M
Radiology; 1992 Dec; 185(3):903-4. PubMed ID: 1438783
[TBL] [Abstract][Full Text] [Related]
30. Plasma retinol-binding protein levels of children under five years of age in a displaced Sudanese community.
el Bushra HE; Ash LR; Neumann CG
East Afr Med J; 1994 Oct; 71(10):647-50. PubMed ID: 7821244
[TBL] [Abstract][Full Text] [Related]
31. Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A.
Garrett-Laster M; Russell RM; Jacques PF
Hum Nutr Clin Nutr; 1984 May; 38(3):203-14. PubMed ID: 6746322
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of rectal mucosal hemodynamics in patients with liver cirrhosis using reflectance spectrophotometry.
Tezuka T; Akita Y; Yoshikawa N; Mitamura K
Am J Gastroenterol; 1997 Jun; 92(6):1022-5. PubMed ID: 9177523
[TBL] [Abstract][Full Text] [Related]
33. True deficiency of antioxidant vitamins E and A in dialysis patients. Relationship with clinical patterns of atherosclerosis.
Aguilera A; Bajo MA; del Peso G; Diez JJ; Codoceo R; Rebollo F; Mariano M; Selgas R
Adv Perit Dial; 2002; 18():206-11. PubMed ID: 12402620
[TBL] [Abstract][Full Text] [Related]
34. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.
Conn HO; Rössle M; Levy L; Glocker FX
Scand J Gastroenterol; 2006 May; 41(5):619-25. PubMed ID: 16638707
[TBL] [Abstract][Full Text] [Related]
35. [Serum retinol-binding protein (RBP) and the evaluation of vitamin A nutritional status].
Wang XS
Sheng Li Ke Xue Jin Zhan; 1980 Mar; 11(3):220-6. PubMed ID: 6791279
[No Abstract] [Full Text] [Related]
36. [Transjugular intrahepatic portosystemic shunt before hepatic surgery in a patient with cirrhosis and portal hypertension: case report].
Chalret Du Rieu M; Carrere N; Bureau C; Lagarde S; Otal P; Pradere B
J Chir (Paris); 2009 Apr; 146(2):191-4. PubMed ID: 19535077
[TBL] [Abstract][Full Text] [Related]
37. Vitamin A and zinc status in patients on maintenance haemodialysis.
Cabral PC; Diniz Ada S; de Arruda IK
Nephrology (Carlton); 2005 Oct; 10(5):459-63. PubMed ID: 16221095
[TBL] [Abstract][Full Text] [Related]
38. [Some pathogenetic aspects of developing liver failure and preventing it in patients with liver cirrhosis after portosystemic shunting].
Nazyrov FG; Akilov KhA; Ibadov RA; Asabaev ASh; Zaĭnutdinov UI; Khafizov BB
Vestn Khir Im I I Grek; 2002; 161(1):87-90. PubMed ID: 12048797
[TBL] [Abstract][Full Text] [Related]
39. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
40. Electrochemical determination of all-trans-retinol, and correlation with retinol binding protein in liver cirrhosis.
Wring SA; Hart JP
Med Lab Sci; 1989 Oct; 46(4):367-9. PubMed ID: 2615588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
